Options for HER2-positive breast cancer grew in 2013
Added: Monday 6 January 2014
Dr Kimberley Blackwell argues that treatment options for HER2-driven breast cancer increased in 2013. She lists recent clinical advances and describes it as a "breakthrough year" for this type of cancer.
In order to be able to see the content from the www.medscape.com pages, please create first a free account at following link: